Popular Articles

US FDA say GSK vaccine blocks cancer virus
The US Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer.

Rakesh Mohan to join McKinsey as part-time global advisor
Former Reserve Bank of India Deputy Governor Rakesh Mohan will join consulting firm McKinsey as a part-time global advisor from October this year.

News of the day

Govt working on proposal to divest stake in CIL: Jaiswal
Coal Minister Sriprakash Jaiswal today said his ministry is working on proposal to disinvest 5-10 per cent stake in navratna PSU Coal India.
International Business

UNAIDS welcomes plan to reduce price of essential medicine

UNAIDS has welcomed the effort of the Clinton Foundation in association with the major pharmaceutical companies – Pfizer and Matrix – to reduce the prices of antiretroviral drugs for people living with AIDS and tuberculosis. - Clinton Foundation, Mylan & Matrix tie up for HIV drugs - Mylan, Clinton Foundation to offer HIV drugs at lower prices - Clinton deal lowers HIV drug cost in poor nations - Pfizer ups stake in Indian arm to 71% - South Africa tests AIDS vaccine - Pfizer ups offer for stake in Indian arm Former US President Bill Clinton, who heads the Clinton Foundation, had made an announcement in this regard in New York on Thursday. "The reduction of prices of second line antiretroviral drugs will save lives," said Michel Sidibe, Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). "These agreements will help improve the sustainability of national treatment programmes over the long term," Sidibe said. Second line antiretroviral drugs were necessary when people living with HIV – currently estimated 33 million worldwide – fail to respond to standard treatment regimens.At the end of last year, an estimated five per cent of the four million people on antiretroviral treatment required second line drugs. The need for these drugs was expected to rise in the coming years. UNAIDS said the agreement with Matrix to make available three second line drugs in a single package will also contribute to the ease of delivery and help increase treatment adherence. The agreement with Pfizer will enable people to seek treatment for TB – a leading cause of death for those living with AIDS – without interrupting their second line treatment. "People living with HIV should not have to choose between TB and AIDS treatment," Sidibé said. "We have to stop people living with HIV from dying of TB." Meanwhile, UN Deputy High Commissioner for Human Rights Kyung-wha Kang is slated to attend the five-day International Congress on AIDS in Asia and the Pacific in Bali, Indonesia, starting Sunday. Kang is expected to send a clear message stressing that the protection of human rights is indispensable in addressing the AIDS epidemic. "HIV is not just a virus," she said. "It"s also about people who endure discrimination and a wide array of human rights violations."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):